The global cardiovascular information system (CVIS) market size reached US$ 1,033.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,715.9 Million by 2028, exhibiting a growth rate (CAGR) of 9.07% during 2023-2028.
The CVIS refers to a digitized software solution that collects clinical information in the form of electronic medical records (EMR). It incorporates echocardiography, hemodynamics monitoring, vascular ultrasound, electrophysiology, and cardiac and peripheral catheterization. It can store images, informatics, waveforms and patient reports across multiple locations in real-time and can also collect large amounts of data, which are further analyzed for accurate diagnosis of a cardiac ailment. This aids in improving patient safety, streamlining workflows, reducing errors by eliminating duplicate entries, thus enabling physicians to make accurate therapeutic decisions.
The growing medical industry, along with the prevalence of various cardiovascular ailments, is one of the key factors driving the growth of the market. With the growing geriatric population and sedentary lifestyle habits, there is a significant rise in the number of patients suffering from cardiac failures, ischemic heart disease (IHD) and arrhythmia across the globe. Furthermore, the emerging trend of digitization and advancements in the healthcare information technology (IT) sector, are also providing a boost to the market growth. Healthcare institutions are using the system for accessing medical data and images remotely, which consequently enhances the efficiency and interoperability of diagnostic centers. Additionally, the steadily increasing adoption rate of zero-footprint systems is acting as another growth-inducing factor. The CVIS eliminates the need for additional hard drives to store the software as it can transfer data through the web and provides the flexibility of delivery, along with the efficient review of compressed data sets. Other factors, including the rising demand for data-driven technologies, technological advancements and extensive research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular information system market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, component, mode of operation, end-user and application
Breakup by Type:
CVIS (Cardiovascular Information System)
C-PACS (Cardiology Picture Archiving and Communication System)
Breakup by Component:
Breakup by Mode of Operation:
Breakup by End-User:
Hospitals and Clinics
Cardiac Cath Labs
Breakup by Application:
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being Agfa Healthcare India Private Limited, Cerner Corporation, Digisonics Inc., Fujifilm Medical Systems, GE Healthcare, LUMEDX Corporation, McKesson Corporation, Merge Healthcare, Inc., Koninklijke Philips N.V. and Siemens Healthineers AG.
Base Year of the Analysis
Type, Component, Mode of Operation, End-User, Application, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Agfa Healthcare India Private Limited, Cerner Corporation, Digisonics Inc., Fujifilm Medical Systems, GE Healthcare, LUMEDX Corporation, McKesson Corporation, Merge Healthcare, Inc., Koninklijke Philips N.V. and Siemens Healthineers AG
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global cardiovascular information system market was valued at US$ 1,033.3 Million in 2022.
We expect the global cardiovascular information system market to exhibit a CAGR of 9.07% during 2023-2028.
The growing advancements in the healthcare IT sector, along with the rising application of cardiovascular information systems for accurate diagnosis of cardiac ailments, are primarily driving the global cardiovascular information system market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of cardiovascular information systems to remotely enhance the efficiency of the diagnosis process and improve the patient safety during the lockdown scenario.
Based on the type, the global cardiovascular information system market can be segmented into Cardiovascular Information System (CVIS) and Cardiology Picture Archiving and Communication System (C-PACS). Currently, Cardiovascular Information System (CVIS) holds the majority of the total market share.
Based on the component, the global cardiovascular information system market has been divided into software, hardware, and services, where software exhibits a clear dominance in the market.
Based on the mode of operation, the global cardiovascular information system market can be categorized into web-based, onsite, and cloud-based. Among these, web-based operations currently account for the majority of the global market share.
Based on the end-user, the global cardiovascular information system market has been segregated into hospitals and clinics, cardiac cath labs, diagnostic centers, and others. Currently, hospitals and clinics hold the largest market share.
Based on the application, the global cardiovascular information system market can be bifurcated into catheterization, echocardiography, electrocardiogram, nuclear cardiology, and others. Among these, catheterization exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global cardiovascular information system market include Agfa Healthcare India Private Limited, Cerner Corporation, Digisonics Inc., Fujifilm Medical Systems, GE Healthcare, LUMEDX Corporation, McKesson Corporation, Merge Healthcare, Inc., Koninklijke Philips N.V. and Siemens Healthineers AG.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.